Intensity Therapeutics Inc

XNAS:INTS

4.24

+0.09 (+2.17%)

6:27:58 PM EDT: $4.29 +0.05 (+1.18%)

Intensity Therapeutics Inc Stock, XNAS:INTS

1 Enterprise Drive, Suite 430, Shelton, Connecticut 06484-4779

United States of America

Phone: +1.203.221.7381

Number of Employees: 16

http://www.intensitytherapeutics.com

Description

Intensity Therapeutics, Inc. operates as biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. The company was founded by Lewis H. Bender in 2012 and is headquartered in Shelton, CT.